Clinical Trial Update: Zymfentra (Infliximab-dyyb) REal World Cohort STudy

View source ↗

Summary

A real-world cohort study of Zymfentra (Infliximab-dyyb) is being conducted by the University of North Carolina, Chapel Hill to evaluate its use in inflammatory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Indeterminate Colitis
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Zymfentra (Infliximab-dyyb)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Ulcerative Colitis (UC), Crohn's Disease (CD) | Status: RECRUITING